AGO1 and neurodevelopmental disorder: Recently, pathogenic variants and gross deletions involving AGO1 have been associated with neurodevelopmental disorders in humans, including autism spectrum disorder, developmental delay, intellectual disability, and dysmorphic facial features [64].